Advisor Group Holdings, Inc. Pharming Group N.V. Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Pharming Group N.V. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 568 shares of PHAR stock, worth $4,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
568Holding current value
$4,260% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHAR
# of Institutions
6Shares Held
50.1KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY23.4KShares$175,7620.19% of portfolio
-
Cowen Prime Advisors LLC22.5KShares$168,4500.09% of portfolio
-
Morgan Stanley New York, NY2.8KShares$21,0000.0% of portfolio
-
Ubs Group Ag789Shares$5,9170.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $489M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...